Recent research indicates that GLP-1 weight-loss drugs, such as semaglutide, may not only aid in weight management but also extend lifespan in older female mice. The study found that these mice lived approximately 12 percent longer than their untreated counterparts, suggesting p…
A study published in Nature suggests that GLP-1 obesity drugs, such as semaglutide, may extend lifespan and improve health in older female mice. The research indicates that treate…
Eli Lilly has reported a significant revenue increase of 47% in the second quarter, reaching $22.97 billion, despite a decline in employer insurance coverage for GLP-1 weight-loss…
New research indicates that individuals who consistently log their food intake may experience greater weight loss. An analysis of over 5,000 adults using a nutrition-tracking app…
GLP-1 medications, known for their role in treating diabetes and obesity, are being studied for additional health benefits, including improvements in heart health and potential ca…
Health and Human Services Secretary Robert F. Kennedy Jr. has recently claimed a 3% drop in obesity rates, attributing it partially to the Trump administration's policies. However…
GLP-1 receptor agonists, initially developed for diabetes treatment, are being studied for their effects on weight loss and metabolic health in older adults. Recent research sugge…
Recent data indicates a potential decline in obesity rates in the United States, marking a significant shift in a longstanding public health issue. This change coincides with the…
New research from Yale University has uncovered surprising effects of Ozempic, a GLP-1 medication, on hunger neurons in the brain. Contrary to previous beliefs that these neurons…
A recent Gallup poll indicates that only 54% of Americans report drinking alcohol, matching the lowest level since 1939. This decline reflects growing public awareness of alcohol'…
Geneticist Nir Barzilai is leading efforts to explore how existing medications could be repurposed to extend health span and address age-related diseases. His research focuses on…
The death of 19-year-old Josephine Nasr, a law student in London, has sparked serious concerns regarding the safety of tirzepatide, a GLP-1 weight loss drug. Following her prescri…
The beauty industry is rapidly evolving in response to the adoption of GLP-1 weight-loss drugs, creating a new market for beauty products that promise to counteract the side effec…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…